• Salvianolic Acid B: Readouts That Matter

  2026-08-26

  Salvianolic acid B, also called Dan Shen Suan B, links LH2-associated collagen remodeling with pulmonary fibrosis assay design. This guide presents a causal, orthogonal framework for distinguishing reduced collagen deposition from genuine changes in matrix biology.

• RIP3 Stoichiometry Tunes Necrosome Signaling

  2026-08-26

  The reference study combines quantitative STORM imaging with mathematical modeling to show that necrosomes use an approximately 3:1 RIP3:RIP1 ratio to balance signal amplification with attenuation during necroptosis. Its finding that excessive RIP3 oligomerization suppresses signaling provides a mechanistic explanation for threshold behavior and offers a framework for interpreting higher-order signalosome regulation.

• Naloxone Hydrochloride: Receptor Blockade to Translation

  2026-08-25

  Naloxone hydrochloride is more than a standard opioid receptor antagonist. Its value as a translational research tool spans receptor signaling, withdrawal-associated behavior, neural stem cell proliferation modulation, and assay quality control. This article connects mechanistic evidence with practical study design and product-selection guidance.

• DiscoveryProbe Protease Inhibitor Library in HCC

  2026-08-25

  The DiscoveryProbe Protease Inhibitor Library converts broad protease biology into an automation-ready screening workflow for biochemical, cellular, and high-content assays. Its chemical diversity is especially useful for separating protease activity modulation from downstream effects in apoptosis and hepatocellular carcinoma research.

• Ac-YVAD-CMK Workflow for Caspase-1 Studies

  2026-08-24

  Ac-YVAD-CMK helps distinguish caspase-1-dependent cytokine maturation from upstream membrane injury in infection and pyroptosis models. This practical workflow translates Kupffer cell and TMEM16F findings into controlled assays for IL-1β, IL-18, cell death, and inflammatory signaling.

• Esculin Mechanisms in Renal Cell Carcinoma

  2026-08-24

  A 2024 Biomolecules study combines network pharmacology, molecular docking, and cell-based validation to examine how esculin may suppress renal cell carcinoma. The findings associate esculin with reduced proliferation and migration, increased cell death, and GAPDH-linked modulation of PI3K/Akt signaling, while remaining preliminary because the evidence is computational and in vitro.

• Chenodeoxycholic Acid: Reliable FXR Assays

  2026-08-23

  Learn how Chenodeoxycholic Acid (SKU B1908) can support reproducible FXR, viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers solubility, vehicle controls, protocol design, mechanistic interpretation, and practical vendor selection.

• CCT007093: From PPM1D to p38 Signal Logic

  2026-08-22

  Explore how CCT007093, a PPM1D inhibitor, converts phosphatase control into measurable p38 signaling and cell-death phenotypes. This article emphasizes causal assay design across breast cancer and kidney-injury models rather than repeating a conventional workflow.

• Nigericin Sodium Salt in Cancer Drug Assays

  2026-08-22

  Use Nigericin sodium salt as a controlled potassium ionophore to probe how ion gradients and cytoplasmic pH influence cell-state measurements. A workflow that pairs this perturbation with separate proliferation and cell-killing readouts can reveal drug-response differences hidden by a single viability endpoint.

• Polymyxin B: LPS Biology for Better Assays

  2026-08-21

  Polymyxin B sulfate is more than a membrane-active antibiotic: it is a powerful experimental perturbation for linking bacterial viability, LPS structure, and innate immune signaling. This guide explains how to use it rigorously in Gram-negative infection research and interpret results alongside microbiome-driven immunotherapy findings.

• From Glucose Uptake to Hepatic Insulin Resistance

  2026-08-20

  A mechanistic framework for using glucose uptake measurements to investigate how the Galectin-1–FIP200 axis links impaired autophagy with hepatic steatosis and insulin resistance. The article explains how the WST-8 Glucose Uptake Assay Kit can support translational studies while highlighting essential controls, interpretation limits, and opportunities for model development.

• Dextromethorphan Hydrobromide in Neuroprotection

  2026-08-20

  Dextromethorphan hydrobromide is an NMDA receptor antagonist for dissecting excitotoxicity, ion-channel signaling, and neuroprotection. This guide adds an assay-design perspective, showing how to distinguish direct channel effects from downstream protection and how to interpret evidence across disease models.

• Miltefosine Activates Ras/MEK/ERK in Leukopenia

  2026-08-19

  The reference study identifies Miltefosine as a small-molecule strategy for leukopenia that promotes neutrophil differentiation and restores myelopoiesis after irradiation. Its combination of cell-based assays, a murine model, transcriptomics, network pharmacology, molecular docking, and ERK inhibition supports the Ras/MEK/ERK cascade as a central mechanism, while leaving clinical translation and pathway selectivity for future work.

• Withania somnifera Digestion: LC–MS/MS Insights

  2026-08-19

  A 2026 study combined simulated gastrointestinal digestion, LC–MS/MS, molecular networking, and untargeted metabolomics to determine how Withania somnifera leaf and root extracts change before absorption. Withaferin A and withanoside IV were transformation-prone, whereas withanolide A was comparatively stable, highlighting the importance of digestive stability in botanical pharmacokinetic research.

• ZCL278: Selective Cdc42 Inhibitor Guide

  2026-08-18

  ZCL278 is a selective Cdc42 inhibitor with a reported Kd of 11.4 μM and activity in cancer, neuronal, and fibroblast models. Its strongest use is mechanistic interrogation of Cdc42-dependent cell motility, neuronal morphology, and GTPase signaling rather than clinical treatment.

3646 records 1/244 page Next 12345 下5页 Last page